Safety and Performance Study of the Siello S Pacing Lead
Stopped On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing SIELLO Post Approval Registry to a new EP PASSION real-world data methodology.
Conditions
- Safety and Effectiveness of the Siello S Lead
Interventions
- DEVICE: market-released BIOTRONIK pacemaker system including one or two Siello S leads.
Sponsor
Biotronik, Inc.